Farther Finance Advisors LLC boosted its position in shares of Centene Corporation (NYSE:CNC - Free Report) by 94.6% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 62,736 shares of the company's stock after buying an additional 30,491 shares during the quarter. Farther Finance Advisors LLC's holdings in Centene were worth $3,897,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also made changes to their positions in the company. BlackRock Inc. purchased a new stake in Centene in the 2nd quarter worth about $2,660,422,000. Wellington Management Group LLP boosted its position in shares of Centene by 423.0% during the second quarter. Wellington Management Group LLP now owns 13,301,215 shares of the company's stock valued at $853,805,000 after buying an additional 10,757,914 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Centene by 12.4% during the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,517,580 shares of the company's stock valued at $354,173,000 after buying an additional 608,249 shares during the period. Bank of America Corp DE bought a new position in shares of Centene during the second quarter valued at approximately $285,713,000. Finally, Deutsche Bank AG bought a new position in shares of Centene during the second quarter valued at approximately $257,279,000. Hedge funds and other institutional investors own 93.63% of the company's stock.
Analyst Upgrades and Downgrades
Several analysts have recently weighed in on the company. Weiss Ratings upgraded Centene from a "sell (d)" rating to a "sell (d+)" rating in a research report on Thursday. Morgan Stanley set a $66.00 price target on shares of Centene in a report on Wednesday, July 29th. JPMorgan Chase & Co. raised their price target on shares of Centene from $60.00 to $67.00 and gave the stock a "neutral" rating in a research note on Tuesday, August 4th. Argus upgraded shares of Centene from a "hold" rating to a "buy" rating and set a $80.00 price objective for the company in a report on Tuesday, August 11th. Finally, Cantor Fitzgerald reissued an "overweight" rating on shares of Centene in a research report on Friday. Nine investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, Centene has an average rating of "Hold" and an average target price of $70.05.
Check Out Our Latest Stock Report on CNC
Insider Buying and Selling at Centene
In other news, General Counsel Christopher Koster sold 56,500 shares of the stock in a transaction that occurred on Wednesday, August 26th. The shares were sold at an average price of $66.90, for a total transaction of $3,779,850.00. Following the transaction, the general counsel directly owned 248,854 shares in the company, valued at approximately $16,648,332.60. This trade represents a 18.50% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.37% of the company's stock.
Centene Stock Performance
Shares of Centene stock opened at $65.32 on Monday. The firm has a market cap of $32.27 billion, a P/E ratio of -6.26, a P/E/G ratio of 0.41 and a beta of 1.13. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.71. Centene Corporation has a 12 month low of $31.63 and a 12 month high of $69.63. The stock's fifty day moving average price is $64.99 and its 200-day moving average price is $58.58.
Centene (NYSE:CNC - Get Free Report) last released its quarterly earnings data on Monday, July 27th. The company reported $2.51 earnings per share for the quarter, beating the consensus estimate of $1.09 by $1.42. Centene had a positive return on equity of 12.12% and a negative net margin of 2.51%. The firm had revenue of $53.58 billion during the quarter, compared to the consensus estimate of $47.64 billion. During the same period in the previous year, the company posted ($0.16) earnings per share. The firm's quarterly revenue was up 9.9% on a year-over-year basis. On average, equities research analysts expect that Centene Corporation will post 4.89 earnings per share for the current fiscal year.
Centene Company Profile
(
Free Report)
Centene Corporation NYSE: CNC is a healthcare enterprise that provides health insurance and related services, primarily through government-sponsored programs. Its offerings include Medicaid plans, Medicare products, health plans sold through the Affordable Care Act marketplace, and services for military families through government-sponsored healthcare programs.
The company also provides pharmacy, behavioral health, specialty healthcare, care management and administrative services through various subsidiaries and partner organizations.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Centene, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.
While Centene currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.